Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination – A report of two UK cases-Reference-Cited by-同舟云学术

Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination – A report of two UK cases

Published:2021-07 Issue: Volume:95 Page:514-517
ISSN:0889-1591
Container-title:Brain, Behavior, and Immunity
language:en
Short-container-title:Brain, Behavior, and Immunity

Author:

Mehta Puja R.^ORCID,Apap Mangion Sean,Benger Matthew^ORCID,Stanton Biba R.,Czuprynska Julia,Arya Roopen,Sztriha Laszlo K.^ORCID

Publisher

Elsevier BV

Subject

Behavioral Neuroscience,Endocrine and Autonomic Systems,Immunology

Reference16 articles.

1. Heparin-induced thrombocytopaenia;Arepally;Blood,2017

2. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series;Benger;Brain Behav. Immun.,2020

3. British Society for Haematology: A message from BSH President, Professor Adele Fielding - March 2021. https://b-s-h.org.uk/about-us/news/a-message-from-bsh-president-professor-adele-fielding-march-2021 (accessed 29 March 2021).

4. The incidence of cerebral venous thrombosis: A cross-sectional study;Coutinho;Stroke,2012

5. Cerebral Venous sinus thrombosis incidence is higher than previously thought. A retrospective population-based study;Devasagayam;Stroke,2016

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influencing factors of early neurological deterioration in COVID-19 -associated acute ischemic stroke;2024-05-28

2. Cardiac and Neurological Complications Post COVID-19 Vaccination: A Systematic Review of Case Reports and Case Series;Vaccines;2024-05-24

3. COVID-19 Vaccines: A Radiological Review of the Good, the Bad, and the Ugly;Indian Journal of Radiology and Imaging;2024-04-21

4. Thrombocytopenia with and without thrombosis following COVID-19 vaccination: long-term management;Research and Practice in Thrombosis and Haemostasis;2024-02

5. A Different Perspective of COVID-19 Pandemic: Efficacy and Safety of mRNA Vaccines in Immunocompetent and Immunocompromised Individuals (Part 3);Experimental and Clinical Transplantation;2024-01